Fernando Kafie, MD
NPI 1790760478 · Vascular Surgery Physician · Pensacola, FL
Enrolled with Medicare as Practitioner - Vascular Surgery · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1790760478
- Entity type
- Individual
- Primary specialty
- Vascular Surgery PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- ME81407 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,645 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Ultrasound of Leg Arteries Or Artery Grafts93925 | 280 | $222 |
| Ultrasound of Both Sides of Head and Neck Blood Flow93880 | 270 | $164 |
| Ultrasound of Hemodialysis Access93990 | 230 | $120 |
| Ultrasound Study of Arm Or Leg Veins With Compression and Maneuvers93970 | 182 | $174 |
| Ultrasound Study of One Arm Or Leg Veins With Compression and Maneuvers93971 | 164 | $111 |
| Ultrasound of Aorta, Vena Cava, Groin Vessels Or Bypass Grafts93979 | 145 | $87 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Clopidogrel Bisulfatebrand: Clopidogrel | 220 | 95 |
| Oxycodone Hcl/Acetaminophenbrand: Oxycodone-Acetaminophen | 114 | 97 |
| Apixabanbrand: Eliquis | 110 | 38 |
| Rivaroxabanbrand: Xarelto | 68 | 21 |
| Lidocaine/Prilocainebrand: Lidocaine-Prilocaine | 27 | 13 |
| Prednisone | 12 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$3,373 across 69 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-12-14
- Last updated
- 2026-05-22
- Certified
- 2026-05-22
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.